CoTOL is a standard Chinese language drugs (TCM) formulation in clinics for treating gout and hyperuricemia, particularly in overweight sufferers with recurrent assaults. Nevertheless, fewer research have investigated how CoTOL impacts the intestinal flora in lowering uric acid. Within the current, we analyze the micro organism focused by elements of CoTOL and consider the consequences of CoTOL on uric acid and intestinal flora in a mice mannequin of overweight hyperuricemia inoculated with xanthine dehydrogenase- (XOD-) producing micro organism, Streptococcus faecalis detected by the adequate antibody.
Firstly, elements of herbs in CoTOL and gene goal by these elements have been retrieved from TCMID 2.0, and these genes have been screened by DAVID Bioinformatics Assets 6.8, deciphered to retrieve the micro organism. Then, 3-4-week-old male C57bl/6j mice have been randomly divided into 6 teams and fed with excessive fats weight loss program for Eight weeks as much as weight problems normal.
The mice have been inoculated intragastrically with 5 × 109 CFU Streptococcus faecalis Three instances on the 5th, 6th, and seventh week and intragastrically administrated with uricase inhibitor, potassium-oxonate (PO, 250 mg/kg), to induce hyperuricemia on the 8th week, as soon as a day for 7 consecutive days, respectively (IB mannequin). IB mannequin plus CoTOL (0.Four ml/20g) and allopurinol (40 mg/kg) have been administrated by gavage on the 5th week, as soon as a day for Four weeks. The feces and blood in every group have been sampled on the 4th and eightth week.
With no micro organism inoculation, CoTOL, allopurinol, and clean group have been handled with CoTOL and allopurinol or water, respectively. 44 species of micro organism (i.e., Enterococcus faecalis, Streptococcus, and so on.) genes have been focused by 6 elements of 6 herbs in CoTOL. Inoculation with Streptococcus faecalis considerably precipitated the elevation of uric acid and the change of intestinal flora construction, whereas therapy with CoTOL significantly elevated the abundance of Akkermansia and people of Bacteroides and Alloprevotella decreased.
Moreover, CoTOL exhibited a singular impact on lowering weight unobserved in allopurinol intervention. The current examine, for the primary time, demonstrated that CoTOL has useful results on hyperuricemia and chubby, which can be attributed to regulating materials metabolism and enhancing the construction or perform of intestinal flora. Thus, CoTOL could also be a promising remedy for hyperuricemia and chubby in persistent gout administration and might be built-in with standard therapies.
8-Hydroxy-2′-Deoxyguanosine and 8-Nitroguanine Manufacturing and Detection in Blood Serum of Breast Most cancers Sufferers in Response to Postoperative Complementary Exterior Ionizing Irradiation of Regular Tissues
It’s broadly recognized that ionizing irradiation is strongly linked to the manufacturing of reactive oxygen (ROS) and nitrative species (RNS) by means of which DNA harm merchandise like 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-nitroguanine (8-NG) are generated, respectively. Within the current examine, we aimed to research the formation of 8-OHdG and 8-NG upon irradiation and to additional discover whether or not alterations of their focus ranges are associated to the administered radiation doses and publicity time. Our analysis work was carried out in blood serum samples collected from 33 breast most cancers sufferers who acquired adjuvant radiotherapy.
The detection of 8-OHdG and 8-NG was assessed by enzyme-linked immunosorbent assay. Our outcomes counsel that each, 8-OHdG and 8-NG, have been fashioned through the radiation routine. Vital correlations with radiation dose have been additionally demonstrated by the dose-response curves of 8-OHdG and 8-NG, fitted by logarithmic distribution and polynomial regression, respectively.
Extra exactly, 8-OHdG and 8-NG concentrations (ng/mL) have been significantly elevated when sufferers acquired ionizing radiation as much as 30 Gy whereas irradiation over 30 Gy didn’t induce any additional will increase. The present examine helps a) the manufacturing of 8-OHdG and 8-NG throughout radiotherapy and b) important correlations between both 8-OHdG or 8-NG ranges and radiation doses, indicating a radiation-dose-dependent relationship.
α-Amylase assay with starch-iodine-sodium fluorescein-based fluorometric technique in human serum samples
A brand new fluorometric technique was developed for the dedication of α-amylase exercise in human serum samples. Firstly, a saturated starch-iodine complicated (SI) was ready. The SI complicated was mixed with sodium fluorescein to kind a starch-iodine-sodium fluorescein complicated (SIF). Because the SIF complicated decomposes with the α-amylase enzymatic hydrolysis of starch, the depth of its fluorescence emission will increase. The α-amylase exercise is decided utilizing the elevated fluorescence emission depth following hydrolysis of the SIF complicated by α-amylase.
The optimum pH, optimum buffer focus, optimum temperature, and interference impact have been recognized for the developed fluorometric measurement technique. Below the optimum circumstances, a linear calibration curve was obtained between 0.18 and 9.00 U/L for α-amylase. The α-amylase exercise within the human serum pattern was additionally decided by our ready measurement system and in contrast with the outcome from a medical middle. Each strategies are in good settlement with one another.
As a result of this newly developed fluorometric technique for α-amylase exercise in serum samples is cheap, straightforward to make use of, and carried out to detect a really low quantity of human serum α-amylase with sensitivity, it may be proposed this technique for alpha-amylase exercise assay in all different organic samples.
Impaired host response and the presence of Acinetobacter baumannii within the serum microbiome of type-II diabetic sufferers
Kind II diabetes (T2D) impacts over 10% of the US inhabitants and is a rising illness worldwide that manifests with quite a few comorbidities and defects in irritation. This dysbiotic host response permits for an infection of the host by quite a few microorganisms. In the midst of T2D illness, people can develop persistent infections together with foot ulcers and periodontitis, which result in additional issues and opportunistic infections in a number of physique websites.
 Antibody) Amyloid A, Serum (SAA) Antibody |
|
abx023989-1mg |
Abbexa |
1 mg |
EUR 1052 |
|
|
Amyloid A, Serum (SAA) Antibody |
|
abx023990-1mg |
Abbexa |
1 mg |
EUR 1052 |
|
|
Amyloid A, Serum (SAA) Antibody |
|
abx023991-1mg |
Abbexa |
1 mg |
EUR 1052 |
|
|
Amyloid A, Serum (SAA) Antibody |
|
abx024166-1mg |
Abbexa |
1 mg |
EUR 662 |
|
|
 Antibody) Serum Amyloid A (SAA) Antibody |
|
abx022449-1mg |
Abbexa |
1 mg |
EUR 1017 |
|
|
Serum Amyloid A (SAA) Antibody |
|
abx022450-1mg |
Abbexa |
1 mg |
EUR 1017 |
|
|
Serum Amyloid A (SAA) Antibody |
|
abx022451-1mg |
Abbexa |
1 mg |
EUR 1017 |
|
|
Serum Amyloid A (SAA) Antibody |
|
abx022452-05mg |
Abbexa |
0.5 mg |
EUR 1400 |
|
|
Serum Amyloid A (SAA) Antibody |
|
20-abx178371 |
Abbexa |
-
EUR 398.00
-
EUR 133.00
-
EUR 1094.00
-
EUR 537.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody |
|
20-abx178372 |
Abbexa |
|
|
|
|
Serum Amyloid A (SAA) Antibody |
|
20-abx178374 |
Abbexa |
|
|
|
|
Serum Amyloid A (SAA) Antibody |
|
20-abx174524 |
Abbexa |
|
|
|
|
Serum Amyloid A (SAA) Antibody |
|
48336-100ul |
SAB |
100ul |
EUR 333 |
Serum Amyloid A (SAA) Antibody |
|
48336-50ul |
SAB |
50ul |
EUR 239 |
 Serum amyloid A protein |
|
30-1380 |
Fitzgerald |
500 ug |
EUR 349 |
|
Description: Recombinant Serum amyloid A protein |
 anti-Serum Amyloid A |
|
YF-PA14498 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Serum Amyloid A |
anti-Serum Amyloid A |
|
YF-PA14499 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Serum Amyloid A |
anti-Serum Amyloid A |
|
YF-PA24655 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to Serum Amyloid A |
anti-Serum Amyloid A |
|
YF-PA24656 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to Serum Amyloid A |
 Antibody) Human Serum Amyloid A (SAA) Antibody |
|
13011-05011 |
AssayPro |
150 ug |
EUR 217 |
 Antibody) Serum Amyloid A Protein (SAA1) Antibody |
|
20-abx109401 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Serum Amyloid A Protein (SAA1) Antibody |
|
20-abx110208 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody Pair) Serum Amyloid A (SAA) Antibody Pair |
|
20-abx370045 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Serum Amyloid A (SAA) Antibody Pair |
|
20-abx370635 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Serum Amyloid A (SAA) Antibody Pair |
|
20-abx370785 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
 Antibody) Serum Amyloid A (SAA/2868R) Antibody |
|
BNC432868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC432868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC472868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC472868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCAP2868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCAP2868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC802868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC802868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
 Antibody) Serum Amyloid A Protein (saa) Antibody |
|
abx018140-100ug |
Abbexa |
100 ug |
EUR 384 |
|
|
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC682868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC682868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC812868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC812868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC882868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC882868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC612868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC612868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC942868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC942868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCA2868-250 |
Biotium |
250uL |
EUR 394 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), APC conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNUB2868-100 |
Biotium |
100uL |
EUR 264 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNUB2868-50 |
Biotium |
50uL |
EUR 405 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), 1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNUB2868-500 |
Biotium |
500uL |
EUR 513 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCH2868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCH2868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC042868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC042868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC052868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC052868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCP2868-250 |
Biotium |
250uL |
EUR 394 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), PerCP conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCR2868-250 |
Biotium |
250uL |
EUR 394 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), RPE conjugate, Concentration: 0.1mg/mL |
 Antibody) Serum Amyloid A Protein (SAA) Antibody |
|
abx415337-01mg |
Abbexa |
0.1 mg |
EUR 439 |
|
|
Serum Amyloid A Protein (SAA) Antibody |
|
abx415338-01mg |
Abbexa |
0.1 mg |
EUR 453 |
|
|
Serum Amyloid A Protein (SAA1) Antibody |
|
20-abx210169 |
Abbexa |
|
|
|
|
 Antibody (APC)) Serum Amyloid A (SAA) Antibody (APC) |
|
20-abx178373 |
Abbexa |
|
|
|
|
 Antibody (FITC)) Serum Amyloid A (SAA) Antibody (FITC) |
|
20-abx273958 |
Abbexa |
-
EUR 453.00
-
EUR 244.00
-
EUR 1316.00
-
EUR 634.00
-
EUR 342.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody (FITC) |
|
20-abx274059 |
Abbexa |
-
EUR 467.00
-
EUR 244.00
-
EUR 1386.00
-
EUR 648.00
-
EUR 356.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Serum Amyloid A (SAA) Antibody (Biotin) |
|
20-abx274604 |
Abbexa |
-
EUR 342.00
-
EUR 203.00
-
EUR 857.00
-
EUR 439.00
-
EUR 286.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody (PE)) Serum Amyloid A (SAA) Antibody (PE) |
|
20-abx274642 |
Abbexa |
-
EUR 453.00
-
EUR 244.00
-
EUR 1316.00
-
EUR 634.00
-
EUR 342.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
|
20-abx272067 |
Abbexa |
-
EUR 425.00
-
EUR 230.00
-
EUR 1191.00
-
EUR 578.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
|
20-abx272757 |
Abbexa |
-
EUR 425.00
-
EUR 230.00
-
EUR 1219.00
-
EUR 592.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
|
20-abx273039 |
Abbexa |
-
EUR 453.00
-
EUR 244.00
-
EUR 1288.00
-
EUR 620.00
-
EUR 342.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA) Antibody (FITC) |
|
20-abx273736 |
Abbexa |
-
EUR 453.00
-
EUR 244.00
-
EUR 1288.00
-
EUR 620.00
-
EUR 342.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC402868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC402868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCB2868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNCB2868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC552868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC552868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC702868-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
|
BNC702868-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
 Conjugated Antibody) Serum Amyloid A (SAA) Conjugated Antibody |
|
C48336 |
SAB |
100ul |
EUR 397 |
 Human Serum amyloid A monoclonal antibody |
|
10R-11479 |
Fitzgerald |
1 mg |
EUR 356 |
|
Description: Mouse anti- Human Serum amyloid A protein monoclonal antibody |
) Horse Serum amyloid A (SAA1) |
|
1-CSB-YP020656HO |
Cusabio |
-
EUR 679.00
-
EUR 335.00
-
EUR 2172.00
-
EUR 1051.00
-
EUR 1442.00
-
EUR 435.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Horse Serum amyloid A(SAA1) expressed in Yeast |
) Recombinant Serum Amyloid A (SAA) |
|
4-RPA885Bo01 |
Cloud-Clone |
-
EUR 440.48
-
EUR 221.00
-
EUR 1376.80
-
EUR 525.60
-
EUR 951.20
-
EUR 358.00
-
EUR 3292.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Bovine Serum Amyloid A expressed in: E.coli |
Recombinant Serum Amyloid A (SAA) |
|
4-RPA885Hu01 |
Cloud-Clone |
-
EUR 368.80
-
EUR 202.00
-
EUR 1108.00
-
EUR 436.00
-
EUR 772.00
-
EUR 310.00
-
EUR 2620.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Serum Amyloid A expressed in: E.coli |
Recombinant Serum Amyloid A (SAA) |
|
4-RPA885Mu01 |
Cloud-Clone |
-
EUR 413.60
-
EUR 214.00
-
EUR 1276.00
-
EUR 492.00
-
EUR 884.00
-
EUR 340.00
-
EUR 3040.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Mouse Serum Amyloid A expressed in: E.coli |
Recombinant Serum Amyloid A (SAA) |
|
4-RPA885Rb01 |
Cloud-Clone |
-
EUR 458.40
-
EUR 226.00
-
EUR 1444.00
-
EUR 548.00
-
EUR 996.00
-
EUR 370.00
-
EUR 3460.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rabbit Serum Amyloid A expressed in: E.coli |
 Serum amyloid A /SAA4/CSAA |
|
E21-F15 |
EnoGene |
10ug |
EUR 343 |
 Protein) Amyloid A, Serum (SAA) Protein |
|
abx061449-1mg |
Abbexa |
1 mg |
EUR 1017 |
|
|
 Polyclonal Antibody (Human)) Serum Amyloid A (SAA) Polyclonal Antibody (Human) |
|
4-PAA885Hu01 |
Cloud-Clone |
-
EUR 232.00
-
EUR 2285.00
-
EUR 574.00
-
EUR 289.00
-
EUR 208.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Serum Amyloid A (SAA) |
 Polyclonal Antibody (Mouse)) Serum Amyloid A (SAA) Polyclonal Antibody (Mouse) |
|
4-PAA885Mu01 |
Cloud-Clone |
-
EUR 236.00
-
EUR 2338.00
-
EUR 586.00
-
EUR 294.00
-
EUR 209.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Serum Amyloid A (SAA) |
 Monoclonal Antibody (Human)) Serum Amyloid A (SAA) Monoclonal Antibody (Human) |
|
4-MAA885Hu21 |
Cloud-Clone |
-
EUR 242.00
-
EUR 2444.00
-
EUR 610.00
-
EUR 304.00
-
EUR 212.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Serum Amyloid A (SAA) |
Serum Amyloid A (SAA) Monoclonal Antibody (Human) |
|
4-MAA885Hu22 |
Cloud-Clone |
-
EUR 241.00
-
EUR 2417.00
-
EUR 604.00
-
EUR 301.00
-
EUR 211.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Serum Amyloid A (SAA) |
 Anti-Serum Amyloid A Rabbit Monoclonal Antibody |
|
M01362 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Serum Amyloid A Antibody. Validated in WB and tested in Human. |
 Antibody) Human Serum Amyloid A-4 (SAA4) Antibody |
|
13031-05011 |
AssayPro |
150 ug |
EUR 217 |
 Antibody (Biotin)) Serum Amyloid A Protein (SAA1) Antibody (Biotin) |
|
20-abx105915 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Serum Amyloid A Protein (SAA1) Antibody (Biotin) |
|
20-abx106191 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Serum Amyloid A Protein (SAA1) Antibody (FITC) |
|
20-abx107330 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Serum Amyloid A Protein (SAA1) Antibody (FITC) |
|
20-abx107606 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Serum Amyloid A Protein (SAA1) Antibody (HRP) |
|
20-abx108750 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Serum Amyloid A Protein (SAA1) Antibody (HRP) |
|
20-abx109024 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Serum Amyloid A-1 Protein (SAA1) Antibody |
|
20-abx001392 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
 Antibody) Serum Amyloid A-4 Protein (SAA4) Antibody |
|
abx029249-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Serum Amyloid A-4 Protein (SAA4) Antibody |
|
abx029249-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
On this examine, we investigated the serum of wholesome topics and sufferers with T2D with (T2DP) or with out periodontitis for each microbiome signatures along with cytokine profiles. Surprisingly, we detected the presence of Acinetobacter baumanii within the serum of 23% people with T2D/T2DP examined. In T2DP, IL-1β, TNF-α, MCP-1, IL-6, IL-8, and IFN-γ have been considerably elevated in ABC-positive topics. As an rising pathogen, A. baumanii an infection represents a threat for impaired irritation and the event of comorbidities in topics with T2D.
